Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Caius Radu
University of California Los Angeles, Department: Neurosurgery
Should you be removed from our database? Contact us at [email protected]. Read more below.
SOFIE BIOSCIENCES
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Radu is a founder for the company and a co-investigator for this study.
UCLA SPORE in Brain Cancer
Overall: UCLA SPORE in Brain Cancer NARRATIVE The UCLA Brain Cancer SPORE will support research into new and innovative strategies to diagnose and treat brain cancer, particularly focusing on novel ways to overcome the problem of treatment resistance. Despite many different treatment approaches, the five-year survival rate for glioblastoma (WHO grade IV glioma) patients is still <5%, and there are no definitive cures for this disease. Thus, the proposed research is of relevance to public health, as there is clearly an unmet need for patients with this type of cancer and novel therapeutic approaches are warranted.
Filed on September 15, 2017.
Tell us what you know about Caius Radu's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Caius Radu”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Caius Radu | University of California Los Angeles | Conflict of Interest | SOFIE BIOSCIENCES | Value cannot be readily determined |
| Caius Radu | University of California Los Angeles | Conflict of Interest | Sofie Biosciences | $150,000 - $199,999 |
| Caius Radu | University of California Los Angeles | Financial Disclosure | Trethera Corporation | |
| Caius Radu | University of California Los Angeles | Conflict of Interest | Sofie Biosciences | Value cannot be readily determined |
| Caius Radu | University of California Los Angeles | Financial Disclosure | Trethera Corporation |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.